Introduction: The pathogenesis for poor kidney outcomes in lupus nephritis (LN) remains uncertain. There is limited evidence on the association between angiotensin-converting enzyme (ACE) I/D polymorphism and LN with kidney failure. Objectives: To determine the distribution of ACE I/D alleles and genotypes and the correlation between ACE I/D polymorphism and kidney outcomes in LN participants. Subjects and Methods: A cross sectional study was conducted at Cho Ray Hospital (12/2021-07/2023). The LN participants were stratified into 3 groups based on the kidney function and kidney replacement therapy (KRT) on admission. The ACE I/D polymorphism was identified by the polymerase chain reaction. Results: Among 208 LN participants, 71 were in group 1 (eGFR > 60), 55 in group 2 (eGFR ≤ 60 without KRT), 82 in group 3 (eGFR ≤ 60 with KRT). The skewed distribution among 3 groups were observed in D allele (20.4%, 35.5%, 37.2% in group 1, 2, 3, respectively, p = .003) and DD genotype (2.8%, 14.6%, 12.2% in group 1, 2, 3, respectively, p = .005). The ID/DD genotypes increased the susceptibility of kidney failure (eGFR ≤ 60 vs eGFR > 60: OR = 8.26 for DD genotype, OR = 2.31 for ID genotype) and KRT (KRT vs no KRT: OR = 2.01 for ID genotype). Conclusions: The D allele and ID/DD genotypes are linked with the susceptibility of kidney failure in LN participants.
RigatBHubertCAlhenc-GelasF, et al.An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest1990; 86: 1343–1346.
2.
SatoHAkaiYIwanoM, et al.Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of systemic lupus erythematosus. Lupus1998; 7(8): 530–534.
3.
MohanCPuttermanC. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol2015; 11: 329–341.
4.
HuangAFLiHKeL, et al.Association of angiotensin-converting enzyme insertion/deletion polymorphism with susceptibility to systemic lupus erythematosus: a meta analysis. Int J Rheum Dis2018; 21: 447–457.
5.
TanEMCohenASFriesJF, et al.The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25(11): 1271–1277.
6.
PetriMOrbaiAMAlarcónGS, et al.Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64(8): 2677–2686.
7.
RigatBHubertCCorvolP, et al.PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res1992; 20: 1433.
8.
AnnigeriRAOstermannMTolwaniA, et al.Renal support for Acute kidney injury in the developing World. Kidney International Reports2017; 2(4): 559–578.
9.
ToumaZUrowitzMBIbañezD, et al.SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus2011; 20: 67–70.
10.
BendapudiPKHurwitzSFryA, et al.Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol2017; 4(4): e157–e164.
11.
LaszikZGKambhamNSilvaFG. Chapter 18: thrombotic microangiopathies. In: JennetteJCOJSilvaFGD'AgatiVD (eds). Heptinstall's Pathology of the kidney. 7th ed. Pennsylvania, USA: Lippincott Williams & Wilkins, 2015, pp. 740–815.
12.
ParsaALovettDHPedenEA, et al.Renin-angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis. Genes Immun2005; 6(3): 217–224.
13.
GuanTLiuZChenZ. Angiotensin-converting enzyme gene polymorphism and the clinical pathological features and progression in lupus nephritis. Zhonghua Nei Ke Za Zhi1997; 36(7): 461–464.
14.
AkaiYSatoHIwanoM, et al.Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis. Clin Nephrol1999; 51(3): 141–146.
15.
ZhouTBYinSSQinYH. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility. J Renin-Angiotensin-Aldosterone Syst JRAAS2014; 15(1): 22–31.
